Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
8(35%)
Results Posted
25%(2 trials)

Phase Distribution

Ph early_phase_1
1
4%
Ph phase_3
9
39%
Ph phase_2
2
9%
Ph phase_1
4
17%
Ph phase_4
7
30%

Phase Distribution

5

Early Stage

2

Mid Stage

16

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
1(4.3%)
Phase 1Safety & dosage
4(17.4%)
Phase 2Efficacy & side effects
2(8.7%)
Phase 3Large-scale testing
9(39.1%)
Phase 4Post-market surveillance
7(30.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

23

all time

Status Distribution
Active(15)
Completed(8)

Detailed Status

Completed8
Recruiting7
Not yet recruiting6
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
8
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.3%)
Phase 14 (17.4%)
Phase 22 (8.7%)
Phase 39 (39.1%)
Phase 47 (30.4%)

Trials by Status

recruiting730%
completed835%
enrolling_by_invitation14%
not_yet_recruiting626%
active_not_recruiting14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07570069Phase 1

Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants

Not Yet Recruiting
NCT07257133Phase 4

A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine

Completed
NCT07511400Early Phase 1

The Role of NaV1.8 in Human Pain Models

Recruiting
NCT07463430Phase 4

Suzetrigine for Non-Mastectomy Breast Surgery

Enrolling By Invitation
NCT06628908Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT07231419Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT07548385Phase 3

Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN

Recruiting
NCT07525219Phase 3

Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen

Not Yet Recruiting
NCT07539623Phase 3

Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery

Recruiting
NCT07538570Phase 4

Evaluation of Pain Treatment After Total Knee Arthroplasty

Not Yet Recruiting
NCT07534709Phase 4

Suzetrigine for Opioid-Free Recovery After Cesarean Delivery

Not Yet Recruiting
NCT07378865Phase 1

Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants

Recruiting
NCT06696443Phase 3

Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

Active Not Recruiting
NCT07226700Phase 3

Suzetrigine in Total Hip Arthroplasty

Recruiting
NCT07357376Phase 3

Evaluating Suzetrigine for Pain Control Following TKA

Not Yet Recruiting
NCT07355166Phase 4

Suzetrigine Versus Usual-care Opioids for Postop Pain in Sports

Not Yet Recruiting
NCT06774625Phase 2

This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars

Completed
NCT06887959Phase 4

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

Completed
NCT06887972Phase 4

A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries

Completed
NCT05660538Phase 2

Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23